|
Data for this mutation
| Sample ID | MSH2 | MLH1 | MSH6 | MUTYH | APC |
|---|---|---|---|---|---|
| 37_L13.18523069152892 | - | - | - | - | - |
| 37_L13.18529996167540 | - | - | - | - | - |
| 5_200942320094739AAE890 | - | - | - | - | - |
| 8_F1481481108-940021BA | - | - | - | - | - |
| 8_F1481_85787_08-986031EG | - | - | - | - | - |
| 8_F1481_85997_08-958031EG | - | - | - | - | - |
| Analysis | Result | Date | Origin | PMID/dbSNP |
|---|---|---|---|---|
| MMR function in tumor cells | MSI-H (F1481-4811) | 27/04/12 | 8 (Nancy) | |
| Clinical phenotype | Amsterdam II+ (F1481-4811) | 27/04/12 | 8 (Nancy) |
| Biological significance | Date | Comment |
|---|---|---|
| Causal | 21/02/14 | --- |
|
Consequences of the mutation at the protein level No data available |